Helios Klinikum Emil von Behring

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer5 trials
• Acute myeloid leukaemia1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed3 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Takeda2 trials
• Ariad Pharmaceuticals1 trial
• Intuitive Surgical1 trial
• Nikolaj Frost MD1 trial
• University of Ulm1 trial

Running trials

• Recruiting

  European Real-World Registry for Use of the Ion Endoluminal System

  NCT06923774· Intuitive Surgical· Source

  Contact: Joanna Krist, Dr.

• Active, not recruiting

  Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

  NCT05689671· Phase 4· Nikolaj Frost MD· Source

• Recruiting

  Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project

  NCT01252485· University of Ulm· Source

  Contact: Immanuel Merz

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Lung cancer1 recruiting

Closed trials

• Completed

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· Phase 3· Takeda· Source

• Completed

  A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

  NCT03535740· Phase 2· Ariad Pharmaceuticals· Source

• Completed

  A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

  NCT02716116· Phase 1/2· Takeda· Source